National Taiwan University Hospital: Uterine Cervical Neoplasms trials
The registry lists 13 Uterine Cervical Neoplasms studies with National Taiwan University Hospital as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 1Phase 3 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Extended-field Proton Therapy for Cervical CancerRecruitingNCT07298642Phase 2/3
- Ameliorated Pap Tests and Cervical Cancer Screening ParticipationRecruitingNCT06968871Not applicable
- Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine CervixCompletedNCT02207660
- The Association Between Cervical Cancer Screening and Cancer OccurrenceStatus unknownNCT01015079
- Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial LesionsStatus unknownNCT00872937
- Screening and Identification of Biomarkers on Cervical CancersStatus unknownNCT00854269Not applicable
- The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their PrognosisStatus unknownNCT00728871Not applicable
- Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell FunctionStatus unknownNCT00173290
- The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human BeingStatus unknownNCT00155792
- Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)Status unknownNCT00155766Phase 1
- The Correlation Between Tumor Angiogenesis and the Effect of Radiation Therapy in Cervical Cancer PatientsStatus unknownNCT00155077
- Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical LesionsStatus unknownNCT00154583
- The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human PapillomavirusStatus unknownNCT00154479